Institut National de Veille Sanitaire/ Institut National du Cancer/ Francim/ Institut National de la Santé et de la Recherche Médicale. « Projections de l'incidence et de la mortalité par cancer en France en, 2010. ,
Localization of the estrogen receptor locus (ESR) to chromosome 6q25. 1 by FISH and a simple post-FISH banding technique, Genomics, vol.17, pp.263-268, 1993. ,
Human estrogen receptor betagene structure, chromosomal localization and expression pattern, J Clin Endocrinol Metab, vol.82, pp.4258-65, 1997. ,
DOI : 10.1210/jc.82.12.4258
Hormonothérapie des cancers du sein, Bulletin du cancer, vol.98, issue.11, pp.1311-1320, 2011. ,
Estrogen receptors alpha and beta form heterodimers on DNA, J Biol Chem, vol.272, pp.19858-62, 1997. ,
The estrogen receptor: a model for molecular medicine, Clin Cancer Res, vol.9, pp.1980-1989, 2003. ,
Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha, Mol Endocrinol, vol.11, pp.1486-96, 1997. ,
Molecular basis of agonism and antagonism in the oestrogen receptor, Nature, vol.389, pp.753-761, 1997. ,
Nuclear receptor coregulators : cellular and molecular biology, Endocr Rev, vol.20, pp.321-365, 1999. ,
Peptide antagonists of the human estrogen receptor, Science, vol.285, pp.744-750, 1999. ,
Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA, Biochem Biophys Res Commun, vol.13, issue.1432, pp.740-748, 1987. ,
Localization of the human progesterone receptor gene to chromosome 11q22-q23, Hum Genet, vol.77, issue.3, pp.280-282, 1987. ,
The novel estrogen receptor-beta subtype: potential role in the cell-and promoter-specific actions of estrogens anti-estrogens, FEBS Lett, vol.87, p.41090, 1997. ,
Le tamoxifène et les inhibiteurs d'aromatase dans le traitement des cancers du sein : aspects pharmacologiques et cliniques, Bulletin du cancer, vol.91, issue.12, pp.917-944, 2004. ,
Definition of the molecular and cellular mechanisms underlying the time selective agonist/ antagonist activities of selective estrogen receptor modulators, Recent Prog Horm Res, vol.57, pp.295-316, 2002. ,
The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ER alpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens, Endocrinology, vol.140, pp.5566-78, 1999. ,
Cellular and molecular pharmacology of antiestrogen action and resistance, Pharmacol Rev, vol.53, pp.25-71, 2001. ,
Endocrine-responsive breast cancer and strategies for combating resistance, Nature Rev Cancer, vol.2, pp.101-113, 2002. ,
Selective estrogen receptor modulator: a personal perspective, Cancer Res, vol.61, pp.5683-5690, 2001. ,
Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/ SAF-B, a novel inhibitor of ER-mediated transactivation, Mol Endocrinol, vol.14, pp.369-81, 2000. ,
Effects of Tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase, Cancer Res, vol.43, pp.3583-3588, 1983. ,
Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle, Cancer Res, vol.49, pp.2398-404, 1989. ,
Regulation of insulin-like growth factors by antiestrogen, Breast Cancer Res Treat, vol.31, pp.107-122, 1994. ,
Evidence that transforming growth factor beta is a hormonally regulated negative growth factor in human breast cancer cells, Cell, vol.48, pp.417-445, 1987. ,
Induction of transforming growth factor ?1 in human breast cancer in vivo following tamoxifen treatment, Cancer Res, vol.52, pp.4261-4265, 1992. ,
Species-specific pharmacology of antiestrogen role of metabolism, Fed Proc, vol.46, pp.1870-1874, 1987. ,
Basic guide to the mechanisms of antiestrogen action, Pharmacol Rev, vol.50, pp.151-96, 1998. ,
Tamoxifen therapy in breast cancer control worldwide, Bull World Health Organ, vol.71, pp.795-803, 1993. ,
Selective estrogen receptor modulators: structure, function, and clinical use, J Clin Oncol, vol.18, pp.3172-86, 2000. ,
Skeletal effects of selective oestrogen receptor modulators (SERM) ,
Cancérologie clinique, 2008. ,
Hormonothérapie adjuvante des cancers du sein, Cancer du sein. Actualités thérapeutiques, pp.87-108, 2007. ,
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the national Surgical Adjuvant Breast and Bowel Project B-14 randomized trial, J Natl Cancer Inst, vol.93, pp.684-690, 2001. ,
A randomized trial of Exemestane after two or three years of Tamoxifen Therapy in Postmenopausal women with primary breast cancer, N Engl J Med, vol.350, pp.1081-92, 2004. ,
hormonothérapie du cancer du sein: la fin du Tamoxifène?, Bull Cancer, vol.92, pp.142-150, 2005. ,
Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial, J Clin Oncol, vol.22, pp.1605-1613, 2004. ,
Accidents thromboemboliques chez les patientes ménopausées sous traitement adjuvant par tamoxifène. Fréquence, facteurs de risque et possibilités de prévention, Bull Cancer, vol.82, pp.51-57, 1995. ,
Tamoxifen and risk of idiopathic venous thromboembolism ,
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor positive tumors, J Natl Cancer Inst, vol.88, issue.21, pp.1529-1542, 1996. ,
Increased thromboembolic complication with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group, J Clin Oncol, vol.14, issue.10, pp.2731-2738, 1996. ,
Risk factors associated with endometrial polyps in abnormal uterine bleeding, Int J Gynaecol Obstet, vol.76, issue.2, pp.165-173, 2002. ,
Endometrial cancer in tamoxifentreated breast cancer patients: finding from the National Surgical Adjuvant Breast and Bowel Project (NASBP) B-14, J Natl Cancer Inst, vol.86, issue.7, pp.527-564, 1994. ,
Eviter les effets indésirables par interactions médicamenteuses, Comprendre et décider. Prescrire, le guide 2012, 2011. ,
Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis, Endocr Rev, vol.15, pp.342-355, 1994. ,
Novel aromatase and 5-reductase inhibitors, J Steroid Biochem Mol Biol, vol.49, pp.289-294, 1994. ,
Aminoglutethimide as an inhibitor of adrenal steroidogenesis mechanisms of action and therapeutic trials, J Clin Endocrinol, vol.27, pp.1239-1248, 1967. ,
Clinical applications of new aromatase inhibitors, Critical Reviews in OncologyHematology, vol.16, pp.129-143, 1994. ,
Sex steroid-producing enzymes in human breast cancer, Endocr Relat Cancer, vol.12, pp.701-720, 2005. ,
Comprehensive pharmacology and clinical efficacy of aromatase inhibitors, Drugs, vol.58, pp.233-255, 1999. ,
Anastrozole alone or in combinaison with tamoxifen versus tamoxifen alone for ajuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex Tamoxifen Alone or in Combination) trial efficacy and safety update analyses, Cancer, vol.98, pp.1802-1810, 2003. ,
of the ATAC (Arimidex Tamoxifen Alone or in Combination) trial after completion of 5 years adjuvant treatment for breast cancer, Lancet, vol.365, pp.60-62, 2005. ,
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer, N Engl J Med, vol.353, pp.2747-2757, 2005. ,
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian tamoxifen anastrozole trial, J Clin Oncol, vol.23, pp.5138-5147, 2005. ,
Switching of postmenopausal women with endocrine responsive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial, Lancet, vol.366, pp.455-462, 2005. ,
Place des inhibiteurs de l'aromatase dans le traitement du cancer du sein : aspects pharmacologiques et cliniques, J Pharm Clin, vol.26, pp.5-14, 2007. ,
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma, Cancer, vol.92, pp.2247-2258, 2001. ,
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group, J Clin Oncol, vol.21, pp.2101-2109, 2003. ,
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG1-98, J Clin Oncol, vol.25, pp.486-492, 2007. ,
Improved overall survival in postmenopausal women with early breast cancer after anastrozole initated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 study, J Clin Oncol, vol.25, pp.2664-2670, 2005. ,
Prevalence of joint symptoms in post menopausal women taking aromatase inhibitors for early-stage breast cancer, J Clin Oncol, vol.25, pp.3877-83, 2007. ,
Effect of acupuncture on joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients, breast cancer symposium 29 th annual meeting, 2006. ,
Aromatase inhibitor (AI)-associated arthralgie (A) and bone pain (BP): frequency and characterization in clinical practice, ASCO Annual Meeting Proceedings PartI, p.6137, 2006. ,
Prospective characterization of musculoskeletal symptoms in early breast cancer patients treated with aromatase inhibitors, Breast Cancer Res Treat, pp.10549-10556, 1007. ,
Joint Symptoms : A Practical Problem of Anastrozole, Breast Cancer, vol.13, pp.284-292, 2006. ,
Joint pain with aromatase inhibitors: abnormal frequency of Sjogren's Syndrome, J Rheumatol, vol.34, pp.2259-63, 2007. ,
A prospective sutdy comparing clinical rheumatological findings and tenosynovial and synovial changes on magnetic resonance imaging of breast cancer patients receiving adjuvant aromatase inhibitors or tamoxifene. In: abstract 3053 presented at 30 th annual meeting Breast Cancer Symposium, 2007. ,
Debilating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging, Breast Cancer Res Treat, vol.104, pp.87-91, 2007. ,
Long term toxicities in women with early stage breast cancer treated with aromatase inhibitors: data from a tertiary care center, Breast Cancer Res Treat, vol.100, 2006. ,
Clinical features of joint symptoms observed in the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial, ASCO Annual Meeting Proceedings, p.551, 2006. ,
Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation, Arthritis Rheum, vol.52, pp.2594-2602, 2005. ,
Estrogen and progesterone activate spinal ?opiate receptor analgesic mechanisms, Pain, vol.64, pp.169-77, 1996. ,
Pronociceptive and nociceptive effects of estradiol though endogenous opiod neurotransmission in women, L Neurosci, vol.26, pp.5777-85, 2006. ,
Roles for estrogen in bone loss and arthralgia during aromatase inhibitor treatment, Current Opinion in Oncology, vol.19, pp.1-8, 2007. ,
An alternative methodology for the prediction of adherence to anti HIV treatment, AIDS Res Ther, vol.6, issue.1, p.9, 2009. ,
La decision thérapeutique personnalisée. Observance médicamenteuse, Rev Prat, vol.55, pp.899-902, 2005. ,
Conceptual and methodologic problems in measuring patient compliance, Compliance in health care, 1979. ,
Patient non-compliance: deviance or reasoned decisionmaking?, Soc Sci Med, vol.34, pp.507-520, 1992. ,
DOI : 10.1016/0277-9536(92)90206-6
Adherence to therapy with oral antineoplasic agents, J Natl Cancer Inst, vol.94, pp.652-61, 2002. ,
Education, psychology and « compliance », Diabetes Metab Res Rev, vol.24, pp.101-106, 2008. ,
DOI : 10.1002/dmrr.851
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node negative breast cancer who have estrogen-receptor positive tumors, N Engl J Med, vol.320, pp.479-84, 1989. ,
Role of patient compliance in clinical pharmacokinetics. A review of recent research, Clin Pharmacokinet, vol.27, pp.202-217, 1994. ,
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer, Ann Oncol, vol.20, issue.3, pp.431-467, 2009. ,
Early discontinuation of tamoxifen: a lesson for oncologists, Cancer, vol.109, pp.832-841, 2007. ,
Adherence to initial adjuvant anastrozole therapy among women with early stage breast cancer, J Clin Oncol, vol.26, pp.556-62, 2008. ,
Tamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatment, Tumori, vol.84, pp.372-377, 1998. ,
Compliance with oral drug therapy in patients with hematologic malignancy, J Clin Oncol, vol.5, pp.1469-76, 1987. ,
Time to stop counting the tablets?, Clin Pharmacol Ther, vol.46, pp.163-171, 1989. ,
The natural history of medication compliance in a drug trial: limitations of pill counts, Clin Pharmacol Ther, vol.46, pp.169-76, 1989. ,
Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring, J Clin Oncol, vol.11, pp.1189-97, 1993. ,
Patient adherence and persistence with oral anticancer treatment, CA Cancer J Clin, vol.59, pp.56-66, 2009. ,
Tamoxifen non-compliance: does it matter?, Lancet Oncol, vol.3, p.654, 2002. ,
Non adherence to adjuvant tamoxifen therapy in women with primary breast cancer, J Clin Oncol, vol.21, pp.602-606, 2003. ,
Adherence beliefs among breast cancer patients taking tamoxifen, Patient Educ Couns, vol.59, pp.97-102, 2005. ,
DOI : 10.1016/j.pec.2004.10.005
Intentional and non-intentional non-adherence to medication among breast cancer patients, Eur J Cancer, vol.42, pp.2271-2276, 2006. ,
Association of poor adherence to prescribed tamoxifen with risk of death from breast cancer, Presented at the American Society of Clinical Oncology Breast Cancer Symposium, 2007. ,
Persistence of use of lipid-lowering medications: a cross national study, JAMA, vol.279, pp.1458-62, 1998. ,
Sociobehavioral determinants of compliance, Compliance with therapeutic regimens ,
Health behaviors and pharmacotherapy, Ann Pharmacother, vol.32, pp.1076-86, 1998. ,
DOI : 10.1345/aph.17418
A critical review of the " determinants " of patient compliance with therapeutic regimens, Compliance with therapeutic regimens, pp.26-39, 1976. ,
Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group, BR J Cancer, vol.100, pp.1566-1574, 2009. ,
Predictors of Tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer, J Clin Oncol, vol.26, pp.549-555, 2008. ,
Patient compliance with oral chemotherapy as assessed by a novel electronic technique, J Clin Oncol, vol.10, issue.6, pp.1007-1013, 1992. ,
Predictors of medication adherence in the ederly, Clin Ther, vol.20, pp.764-71, 1998. ,
Symptoms associated with tamoxifen treatment in postmenopausal women, Arch Intern Med, vol.151, pp.1842-1847, 1991. ,
Adherence to medication. The New Englanf Journal of, Medecine, vol.353, pp.487-497, 2005. ,
BSc Amit et al. Interventions to enhance patient adherence to medication prescriptions, JAMA, vol.288, issue.22, pp.2876-2879, 2002. ,
Décision thérapeutique personnalisée. Observance médicamenteuse, Revue du praticien, vol.55, pp.899-902, 2005. ,
Comportements individuels face aux medicaments: de l'observance thérapeutique, à l'expérience de la maladie, analyse de la literature, Santé Publique, vol.4, pp.427-441, 1995. ,
Compliance with antihypertensive therapy among ederly Medicaid enrollees: the role of age, gender and race, Am J Public Health, vol.86, pp.1805-1813, 1996. ,
Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care, Clin Ther, vol.18, pp.1252-62, 1996. ,
observance: clé de voute de traitement au long cours. Revue du praticien Médecine Générale, pp.142-144, 2008. ,
Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors, J Gen Int Med, 2002. ,
Self-efficacity: toward a unifying theory of behavioral change, Psychol Rev, vol.84, pp.191-215, 1977. ,
Generalized expectancies for internal locus of control of reinforcement, Psychol Monogr, vol.80, issue.609, 1966. ,
Psychological distress in cancer patients assessed with an expert rating scale, Br J Cancer, vol.99, pp.37-43, 2008. ,
Health-related quality of life and distress in cancer patients: results from a large randomized study, Br J Cancer, vol.99, pp.1975-1983, 2008. ,
Adjusting to life after treatment: distress and quality of life following treatment for breast cancer, Br J Cancer, vol.97, pp.1625-1631, 2007. ,
Psychological problems of cancer patients: a cancer distress screening with a cancer specific questionnaire, Br J Cancer, vol.91, pp.504-511, 2004. ,
Suicide in cancer patients in south East England from 1996 to 2005: a population based study, Br J Cancer, vol.101, pp.198-201, 2009. ,
Depression and anxiety in women with early breast cancer: five year observational cohort study, BMJ, vol.330, p.702, 2005. ,
Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis, Aust N Z J Psychiatry, vol.38, pp.320-326, 2004. ,
Prevalence of depression in patients with cancer, J Natl Cancer Inst Monogr, vol.32, pp.57-71, 2004. ,
How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer, Br J Cancer, vol.104, pp.419-426, 2011. ,
Communication, compliance and concordance between physicians and patients with prescribed medications, Ann J Public Health, vol.66, pp.847-53, 1976. ,
Evidence on patient-doctor communication, Cancer Prev Control, vol.3, pp.25-30, 1999. ,
The needs of patients with advanced, incurable cancer, Br J Cancer, vol.101, pp.759-764, 2009. ,
Adherence to treatment and health outcomes, Arch Intern Med, vol.153, pp.1863-1871, 1993. ,
Comment le médecin perçoit-il sa prise en compte des préoccupations du patient ? Une étude qualitative en soins primaires en Aquitaine, Medecine, vol.2, issue.1, pp.38-42, 2006. ,
Dose-response effect of adjuvant chemotherapy in breast cancer, N Engl J Med, vol.304, pp.10-15, 1981. ,
The drug defaulter, Clin Pharmacol Ther, vol.13, pp.841-849, 1972. ,
Overview of patient compliance with medication dosing: a literature review, Clin Ther, vol.6, pp.592-601, 1984. ,
Adherence and persistence: impact on outcomes and health care resources, Bone, vol.38, issue.2 2, pp.18-21, 2006. ,
Medication non-adherence-exploring the conceptual mire, Int J Nurse Pract, vol.15, issue.1, pp.25-31, 2009. ,
The ultimate absorption barrier, Novel drug delivery and its therapeutic applications, pp.127-164, 1989. ,
Effectiveness of Interventions to Improve Patient Compliance, Medical Care, vol.36, issue.8, pp.1138-61, 1998. ,
DOI : 10.1097/00005650-199808000-00004
Multidisciplinary Cancer Conferences: Exploring Obstacles and Facilitators to their implantation, Ann S Clin Oncol, vol.6, issue.2, 2010. ,
Patient education: we have a better system now, RN, vol.60, issue.19, pp.22-24, 1997. ,
The prevalence of psychological distress by cancer site, Psycho-Oncology, vol.15, issue.1, pp.19-28, 2001. ,
DOI : 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-6
A New Psychosocial Screening Instrument for Use With Cancer Patients, Psychosomatics, vol.42, issue.3, pp.241-246, 2001. ,
DOI : 10.1176/appi.psy.42.3.241
An Efficient Method for Psychosocial Screening of Cancer Patients, Psychosomatics, vol.31, issue.2, pp.192-196, 1990. ,
DOI : 10.1016/S0033-3182(90)72194-9
Critical Review of Psychosocial Interventions in Cancer Care, Archives of General Psychiatry, vol.52, issue.2, pp.100-113, 1995. ,
DOI : 10.1001/archpsyc.1995.03950140018003
The use of relaxation for the promotion of comfort and pain relief in persons with advanced cancer, Contemporary Nurse, vol.3, pp.6-12, 1994. ,
Randomized trial of group psychosocial support in metastatic breast cancer: the BEST study : Breast Expressive Supportive Therapy Study, Cancer treatment Reviews, vol.22, issue.6, 1996. ,
The Rationale and Foundations Of Group Psychotherapy for Women with Metastatic Breast Cancer, International Journal of Group Psychotherapy, vol.13, issue.2, pp.245-273, 1998. ,
DOI : 10.1016/0277-9536(91)90178-F
Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment, Alternative Therapies in Health and Medicine, vol.3, pp.62-70, 1997. ,
Benefits of psychosocial oncology care: improved quality of life and medical cost offset, Health and Quality of Life Outcomes, vol.1, issue.1, p.8, 2003. ,
DOI : 10.1186/1477-7525-1-8
A controlled trial of cardiac rehabilitation in the home setting using electrocardiographic and voice transtelephonic monitoring, American Heart Journal, vol.139, issue.3, pp.543-548, 2000. ,
DOI : 10.1016/S0002-8703(00)90100-5
Prise en charge pharmaceutique des patients cancéreux. Rôle des pharmaciens hospitaliers et officinaux, 2008. ,
Le conseil associé à une demande spontanée. Tome 2, 2 ème édition, Pro-officina, 2007. ,
Le conseil associé à une ordonnance. Tome 1, 2 ème édition, 2007. ,
Efficacy and Safety of Isopropanolic Black Cohosh Extract for Climacteric Symptoms, Obstetrics & Gynecology, vol.105, issue.5, Part 1, pp.1074-83, 2005. ,
DOI : 10.1097/01.AOG.0000158865.98070.89
Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors, Psycho-Oncology, vol.21, issue.5, pp.487-492, 2007. ,
DOI : 10.1002/pon.1096
Randomized Trial of a Hypnosis Intervention for Treatment of Hot Flashes Among Breast Cancer Survivors, Journal of Clinical Oncology, vol.26, issue.31, pp.5022-5026, 2008. ,
DOI : 10.1200/JCO.2008.16.6389
Acupuncture for treating hot flashes in breast cancer patients: a systematic review, Breast Cancer Research and Treatment, vol.53, issue.3, pp.497-503, 2009. ,
DOI : 10.1007/s10549-008-0230-z
Acupuncture for vasomotor menopausal symptoms, Menopause, vol.16, issue.5, pp.1065-1073, 2009. ,
DOI : 10.1097/gme.0b013e3181a48abd
Randomized, Controlled Trial of Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients, Journal of Clinical Oncology, vol.25, issue.35, pp.5584-90, 200110. ,
DOI : 10.1200/JCO.2007.12.0774
Exercice for vasomotor menopausal symptoms, Cochrane Data Base Sys Rev, vol.4, p.6108, 2007. ,
Non-hormonal interventions for hot flashes in women with a history of breast cancer, Cochrane Data Base Sys Rev, vol.9, p.4923, 2010. ,
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer, New England Journal of Medicine, vol.350, issue.11, pp.1081-92, 2004. ,
DOI : 10.1056/NEJMoa040331
Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence, European Journal of Cancer Care, vol.88, issue.5, pp.402-414, 2007. ,
DOI : 10.1016/S0005-7894(82)80002-6
Effect of acupressure on nausea and vomiting induced by chemotherapy in cancer patients, Minerva Med, vol.97, pp.391-395, 2006. ,
Acupuncture for Postchemotherapy Fatigue: A Phase II Study, Journal of Clinical Oncology, vol.22, issue.9, pp.1731-1735, 2004. ,
DOI : 10.1200/JCO.2004.04.102
Aromatherapy and massage for symptoms relief in patients with cancer, Cochrane Data Base Sys Rev, vol.4, p.2287, 2008. ,
Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies, Medical Oncology, vol.100, issue.Suppl 2, pp.753-65, 2011. ,
DOI : 10.1007/s12032-010-9536-x
Médecines non conventionnelles: legislation et pratiques professionnelles, Th D pharm, 2004. ,
Médecines complémentaires et alternatives suivies par les patients cancéreux en France, Bull Cancer, vol.94, pp.483-491, 2007. ,
Les m??decines compl??mentaires et alternatives, Aider à vivre après un cancer, pp.283-291, 2010. ,
DOI : 10.1007/978-2-287-79501-5_22
Perception about complementary therapies relative to conventionnal therapies among adults who use both: results from a national survey, Ann Intern Med, vol.15, pp.344-351, 2001. ,
Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence, The Oncologist, vol.11, issue.7, pp.732-773, 2006. ,
DOI : 10.1634/theoncologist.11-7-732
Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic Review, Journal of Clinical Oncology, vol.26, issue.4, pp.665-73, 2008. ,
DOI : 10.1200/JCO.2007.13.5905
attrait pour les médecines complémentaires et alternatives en cancérologie : une réalité que les médecins ne peuvent ni ignorer, ni réfuter, Bull Cancer, vol.90, pp.623-631, 2003. ,
DOI : 10.1007/s10269-004-0055-2
Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast, Am J Clin Nutr, vol.68, pp.1431-1467, 1998. ,
Evaluation of Soy Phytoestrogens for the Treatment of Hot Flashes in Breast Cancer Survivors: A North Central Cancer Treatment Group Trial, Journal of Clinical Oncology, vol.18, issue.5, pp.1068-74, 2000. ,
DOI : 10.1200/JCO.2000.18.5.1068
Phytoestrogens: Potential Benefits and Implications for Breast Cancer Survivors, Journal of Women's Health, vol.12, issue.7, pp.617-648, 2003. ,
DOI : 10.1089/154099903322404276
Interactions entre la phytothérapie et les medicaments, Forum Med Suisse, pp.693-700, 2003. ,
Vitamines et micronutriments, Aider à vivre après un cancer, pp.277-281, 2010. ,
DOI : 10.1007/978-2-287-79501-5_21
The role of dietary supplements during cancer therapy, J Nutr, vol.133, pp.3794-3799, 2003. ,
Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic Review, Journal of Clinical Oncology, vol.26, issue.4, pp.665-73, 2008. ,
DOI : 10.1200/JCO.2007.13.5905
Striking Regression of Chronic Radiotherapy Damage in a Clinical Trial of Combined Pentoxifylline and Tocopherol, Journal of Clinical Oncology, vol.17, issue.10, pp.3283-90, 1999. ,
DOI : 10.1200/JCO.1999.17.10.3283
Beta carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers, N Engl J Med, vol.330, pp.1029-1064, 1994. ,
Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?, JNCI Journal of the National Cancer Institute, vol.100, issue.11, pp.773-83, 2008. ,
DOI : 10.1093/jnci/djn148
URL : http://jnci.oxfordjournals.org/cgi/content/short/100/11/773
Acupuncture for insomnia, Cochrane Database Syst Rev, issue.3, p.5472, 2007. ,
Acupuncture and related techniques for postoperative pain: a systematic review of randomized controlled trials, British Journal of Anaesthesia, vol.101, issue.2, pp.151-160, 2008. ,
DOI : 10.1093/bja/aen146
Auricular Acupuncture for Dental Anxiety: A Randomized Controlled Trial, Anesthesia & Analgesia, vol.104, issue.2, pp.295-300, 2007. ,
DOI : 10.1213/01.ane.0000242531.12722.fd
Que sais-je ?, p.126, 2001. ,
Les sp??cificit??s de l'Art-th??rapie en oncologie m??dicale lors de l'accompagnement en fin de vie, Profession artthérapeute, pp.75-78, 2011. ,
DOI : 10.1016/B978-2-294-71144-2.50012-8